Irradiated Hope


Santa Monica, Calif. - With melanoma rates increasing 3 to 5 percent each year, dermatologists can glean some hope from recent study results that found Canvaxin, a therapeutic cancer vaccine, doubled survival rates for patients with advanced melanoma.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.